TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event

Breakout & Setup

Volume Surge

25 Hits · last calculated November 3, 2026 Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Methodology & criteria

Two consecutive trading days each with more than 5 times normal trading volume (average of the preceding 5 trading days) — a volume surge this massive and sustained almost always comes from news, earnings, or large institutional buying. Source: fundamental data.

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) are excluded.

🔔 Watch scanner

Terms in This Scanner Explained

(15)
ADR (Average Daily Range)
The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Scanners that run without the global filters still include them; that is noted below their hit list. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
AI Classification
Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
Analysis (Full Company Analysis)
If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
Avg/Yr 3Y (Average Annual Return)
The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
Earnings Date
The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
EPS (Earnings per Share)
Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
Free Cash Flow (FCF)
Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
Funda Rating (Fundamental Rating A+ to F)
Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
Institutions (Funds & Large Holders)
Funds, pension plans, and asset managers - they move the big money and must disclose their US holdings quarterly. When the number of funds adding to a position rises, that is called institutional accumulation: the fuel behind major trends.
Market Capitalization (Mkt Cap)
The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run. The cap does not apply to scanners that run without the global filters; that is noted below their hit list.
Net Margin
How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
Operating Cash Flow (OCF)
The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
Piotroski F-Score
A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
Sector & Industry
Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
Stage (Weinstein Stages 1-4)
Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
Filter

Rating (traffic light)

Stage

Funda Rating

Piotroski

Columns

This scanner's columns

Extra columns

Tip: clicking a column header sorts the table by that column; a second click flips the direction.

Volume Surge
Symbol Volume × Earnings Avg/Y 3Y Volatility Stage Funda Rating Piotroski MktCap Industry AI Rating Deep Dive Deep-Dive Report Sector Price YTD 6 Mo. 1 Year Off High Price Target RS EPS Rating ADR 10D ADR 30D Beta P/E P/E (f) P/S P/B P/FCF PEG EV/EBITDA EBIT Margin Gross Margin Net Margin ROE ROA Debt/Eq Equity Ratio Sales +/Y Growth Score Div. Yield Payout Ratio Altman Z Inst. % Short % Analysts
RKUNF Rakuten Group, Inc. 1,000.0× — — ⚠ Wildest 10% 88 % — B 61 4 of 9 8.7 $ Internet Retail Sells AI — Consumer Cyclical 4.00 $ -25.0 % -22.4 % -34.8 % −31.1 % — — — — — 0.92 — 526.3 0.5 1.5 15.6 24.33 3.7 3.0 % 52.7 % -2.4 % 0.3 % 0.3 % 8.20 3.5 % +9.6 % 4 0.0 % 30.8 % — 29.9 % — —
BTOC Armlogi Holding Corp. 190.4× — — 79 % Stage 4 D 33 3 of 9 0.2 $ Integrated Freight & Logistics – — — Industrials 2.80 $ -44.6 % -47.3 % -71.9 % −83.4 % -9.1 % 5 9 13.1 % 10.2 % 2.91 — 0.0 0.8 — — — 16.8 — -0.6 % -11.2 % -95.0 % -8.9 % — — +14.0 % 4 0.0 % 0.0 % 1.3 1.8 % 1.2 % 3.0 (1)
TVIV Texas Ventures Acquisition IV Corp 121.5× — — – — D 43 — 0.2 $ Shell Companies – — — Financial Services 10.00 $ — — — −0.5 % — — — — — — — 0.0 — 0.0 — — 0.0 0.0 % — 0.0 % 0.0 % 0.0 % — -7.6 % — — 0.0 % 0.0 % — 7.0 % 0.0 % —
PMN ProMIS Neurosciences Inc. 65.6× — — ⚠ Wildest 10% 156 % — D 25 1 of 9 0.0 $ Biotechnology – — — Healthcare 3.00 $ +119.2 % +14.7 % -68.5 % −39.6 % +416.6 % — — — — -0.25 — 0.0 — 0.4 — — -1.7 0.0 % -471,792.6 % 0.0 % -115.7 % -81.1 % — -13.7 % — — 0.0 % 0.0 % -26.8 74.4 % 2.7 % 4.8 (8)
LITB LightInTheBox Holding Co Ltd ARD 51.7× — — 76 % — B 63 6 of 9 0.0 $ Internet Retail – — — Consumer Cyclical 2.70 $ +36.2 % +18.2 % -42.7 % −20.2 % +96.1 % — — — — 0.02 4.5 526.3 0.2 2.3 — 18.57 5.4 2.2 % 65.1 % 3.9 % -220.8 % 9.4 % — -5.5 % -11.9 % 5 0.0 % 0.0 % -1.7 5.4 % 0.1 % —
BYSI BeyondSpring Inc 43.2× 08/12 +11 % ⚠ Wildest 10% 108 % Stage 4 D 30 2 of 9 0.0 $ Biotechnology – — — Healthcare 0.8059 $ -1.2 % -6.8 % -59.5 % −38.9 % +170.5 % 17 42 5.5 % 8.6 % -0.21 — 10.5 — 3.1 — — 0.0 — 72.0 % 0.0 % -310.5 % -22.9 % -0.01 — -100.0 % 4 0.0 % 0.0 % -72.8 14.6 % 7.2 % 5.0 (1)
PAAC Proem Acquisition Corp I 39.5× — — – — D 35 2 of 9 0.2 $ Shell Companies – — — Financial Services 10.00 $ — — — −0.3 % — — — — — — — 0.0 — 0.0 — — 0.0 0.0 % — 0.0 % 0.0 % 0.0 % — -22.7 % — — 0.0 % 0.0 % — 14.7 % 0.2 % —
PINC Premier Inc 35.9× — — – — D 37 4 of 9 4.1 $ — – — — — 49.30 $ — — — −0.7 % -43.3 % — — — — 0.61 290.3 20.0 4.1 1.5 15.4 1.63 16.4 11.4 % 73.0 % -3.3 % 0.9 % 3.0 % 0.18 49.4 % -10.9 % 3 0.0 % 2.0 % 1.6 85.8 % 23.0 % 2.9 (8)
ABOS Acumen Pharmaceuticals Inc 26.8× 08/11 -19 % ⚠ Wildest 10% 253 % Stage 2 D 36 1 of 9 0.0 $ Biotechnology Neutral — Healthcare 0.2397 $ +14.2 % +28.2 % -89.2 % −38.6 % +230.4 % 78 42 7.9 % 6.8 % 0.33 — 0.0 — 0.2 — — -0.6 — -26,379.0 % 0.0 % -93.2 % -45.8 % 0.36 — -100.0 % 2 0.0 % 0.0 % -6.5 64.2 % 6.1 % 5.0 (6)
TDAC Translational Development Acquisition Corp. 25.4× — — 3 % — D 39 2 of 9 0.2 $ Shell Companies – — — Financial Services 10.80 $ +3.5 % +3.2 % +3.5 % −0.1 % — — — — — — 38.4 0.0 — 1.3 — — 0.0 0.0 % — 0.0 % 0.0 % -0.5 % 0.00 96.4 % — — 0.0 % 0.0 % 21.6 87.9 % 0.0 % —
PONO Pono Capital Four, Inc. 25.1× — — – — D 43 — 0.2 $ Shell Companies – — — Financial Services 10.00 $ — — — −0.4 % — — — — — — — 0.0 — 0.0 — — 0.0 0.0 % — 0.0 % 0.0 % 0.0 % — — — — 0.0 % 0.0 % — 81.5 % 0.0 % —
XTER Karman Line Acquisition Corp. 23.1× — — – — D 43 — 0.3 $ — – — — — 9.80 $ — — — −0.2 % — — — — — — — 0.0 — 0.0 — — 0.0 0.0 % — 0.0 % 0.0 % 0.0 % — — — — 0.0 % 0.0 % — 0.0 % 0.0 % —
TBPH Theravance Biopharma Inc 19.9× 08/11 +19 % 46 % Stage 1 C 53 5 of 9 0.9 $ Biotechnology – — — Healthcare 17.00 $ -9.3 % -8.9 % +23.5 % −17.3 % +3.9 % 64 42 2.8 % 2.3 % 0.25 7.7 9.7 8.2 3.1 15.9 — 8.6 — 75.1 % 51.6 % 50.2 % 1.3 % 0.25 — +66.9 % 8 0.0 % 0.0 % 6.3 99.1 % 5.2 % 3.8 (4)
ALDF Aldel Financial II Inc. 19.8× — — 3 % — C 53 4 of 9 0.3 $ Shell Companies – — — Financial Services 10.80 $ +2.8 % +2.6 % +3.0 % 0 % — — — — — — 51.3 0.0 — 1.3 — — 0.0 0.0 % — 0.0 % 94.3 % -0.2 % 0.00 100.0 % — — 0.0 % 0.0 % — 104.9 % 0.0 % —
SVAQ Silicon Valley Acquisition Corp. 18.5× — — – — D 43 — 0.3 $ Shell Companies – — — Financial Services 10.20 $ — — — −0.6 % — — — — — — — 0.0 — 0.0 — — 0.0 0.0 % — 0.0 % 0.0 % 0.0 % 0.00 95.9 % — — 0.0 % 0.0 % — 76.6 % 0.0 % —
NCSM NCS Multistage Holdings Inc 13.4× 07/30 +60 % 74 % Stage 1 D 41 5 of 9 0.1 $ Oil & Gas Equipment & Services – — — Energy 53.40 $ +22.1 % +6.0 % +40.0 % −48.0 % +5.0 % 34 93 3.6 % 5.0 % 0.21 — 9.7 0.7 — 7.5 — 7.7 — 40.1 % 7.6 % 17.6 % 1.4 % — — +13.6 % 5 0.0 % 0.0 % 7.2 73.9 % 4.8 % —
TLSA Tiziana Life Sciences Ltd 11.4× — — 81 % — D 32 1 of 9 0.1 $ Biotechnology – — — Healthcare 0.67 $ -32.2 % -31.8 % -56.5 % −58.9 % +750.8 % — — — — 0.44 — 0.0 — 1,642.1 — — -6.0 0.0 % — 0.0 % -924.3 % -103.2 % 4.27 0.4 % — — 0.0 % 0.0 % -5.0 3.2 % 7.3 % 5.0 (2)
HCIC Hennessy Capital Investment Corp. VIII 10.0× — — – — D 35 2 of 9 0.4 $ Shell Companies – — — Financial Services 10.00 $ — — — −0.3 % — — — — — — — 0.0 — 0.0 — — 0.0 0.0 % — 0.0 % 0.0 % 0.0 % — -5.7 % — — 0.0 % 0.0 % — 78.5 % 0.0 % —
ETSS Energy Transition Special Opportunities 7.5× — — – — D 43 — 0.2 $ Shell Companies – — — Financial Services 9.90 $ — — — −0.8 % — — — — — — — 0.0 — 0.0 — — 0.0 0.0 % — 0.0 % 0.0 % 0.0 % — -6.3 % — — 0.0 % 0.0 % — 9.1 % 0.0 % —
KWM K Wave Media Ltd. 7.4× — — ⚠ Wildest 10% 158 % — C 53 4 of 9 0.0 $ Entertainment – — — Communication Services 0.6276 $ +452.4 % +183.1 % -98.8 % −35.5 % — — — — — 0.39 — 0.0 0.8 0.1 — — 0.0 -53.8 % 18.2 % -263.5 % 0.0 % -45.9 % — -17.0 % +11,099.6 % 2 0.0 % 0.0 % — 5.0 % 0.7 % —
FLNT Fluent Inc 6.1× 08/18 -2 % 76 % Stage 2 C 48 5 of 9 0.1 $ Advertising Agencies – — — Communication Services 3.50 $ +41.3 % +44.9 % +62.0 % −21.9 % +78.6 % 79 99 10.1 % 10.9 % 0.70 — 65.4 0.5 8.2 — 1.81 -3.9 — 26.5 % -11.5 % -137.3 % -13.0 % 2.33 — -18.0 % 3 0.0 % 0.0 % -18.8 33.4 % 0.5 % 3.7 (3)
INAC Indigo Acquisition Corp. 5.5× — — 3 % — B 65 3 of 9 0.2 $ Shell Companies – — — Financial Services 10.40 $ +2.5 % +1.7 % +3.8 % −0.3 % — — — — — — 29.7 0.0 — 1.3 — — 0.0 0.0 % — 0.0 % 0.0 % -0.1 % — -2.8 % — — 0.0 % 0.0 % 22.2 68.7 % 0.0 % —
SXT Sensient Technologies Corporation 5.4× 07/24 +27 % 40 % Stage 2 B 61 5 of 9 5.0 $ Specialty Chemicals – — — Basic Materials 118.20 $ +27.4 % +24.2 % +27.3 % −5.8 % +9.7 % 73 70 4.0 % 3.3 % 0.83 36.1 22.7 2.9 4.3 — 1.74 21.0 15.3 % 34.9 % 9.3 % 12.5 % 6.8 % 0.98 53.3 % +3.5 % 5 1.3 % 41.8 % 10.3 109.7 % 5.4 % 4.0 (5)
OKYO OKYO Pharma Ltd 5.4× — — 73 % — C 53 4 of 9 0.1 $ Biotechnology – — — Healthcare 1.50 $ -26.6 % -23.6 % -43.5 % −51.3 % +495.2 % — — — — -0.06 — 0.0 — 6.7 — — -4.3 0.0 % — 0.0 % -263.8 % -43.1 % 0.00 58.8 % — — 0.0 % 0.0 % -5.2 20.9 % 0.1 % 4.7 (3)
NPKI NPK International Inc. 5.3× 08/04 +74 % 43 % Stage 2 B 59 6 of 9 0.8 $ Building Products & Equipment Neutral — Industrials 9.20 $ +29.4 % +30.1 % -25.5 % −5.9 % +116.3 % 76 50 5.0 % 4.2 % 1.47 — 14.8 2.6 — 70.3 1.30 9.5 18.4 % 35.6 % 14.0 % 10.5 % 7.9 % — 82.2 % +27.4 % 5 0.0 % 0.0 % 8.6 92.9 % 3.0 % 5.0 (3)

Price Chart

Quarterly Figures

No quarterly data available.

Frequently Asked Questions

Two consecutive trading days each with more than 5 times normal trading volume (average of the preceding 5 trading days) — a volume surge this massive and sustained almost always comes from news, earnings, or large institutional buying. Source: fundamental data.

All scanners are recalculated daily across the entire stock universe — most recently on November 3, 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).

Currently, 25 stocks pass this scanner's criteria (as of November 3, 2026).

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) are excluded.

As "normal" volume, we take the average number of shares traded over 5 trading days. A stock makes the scanner when, on two consecutive trading days, more than 5 times this normal volume was traded. Both surge days are measured against the 5 trading days before them — so the first breakout day doesn't skew the yardstick for the second. The "Volume ×" column shows the multiple for the latest trading day; the volume history is updated with each trading day's closing data. A double surge like this is rare and almost always the trace of a real event: earnings, takeover rumors, news — or big money buying in.

Related scanners

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?